Compare RMTI & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMTI | COSM |
|---|---|---|
| Founded | 1994 | 2009 |
| Country | United States | Greece |
| Employees | 300 | 163 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 33.8M |
| IPO Year | 2022 | 2009 |
| Metric | RMTI | COSM |
|---|---|---|
| Price | $8.08 | $0.34 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 21.0K | ★ 3.6M |
| Earning Date | 11-11-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,258,000.00 | $65,271,815.00 |
| Revenue This Year | $4.45 | $23.79 |
| Revenue Next Year | $8.04 | $58.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.93 |
| 52 Week Low | $0.55 | $0.16 |
| 52 Week High | $8.90 | $1.26 |
| Indicator | RMTI | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 47.66 | 53.51 |
| Support Level | $7.39 | $0.27 |
| Resistance Level | $8.42 | $0.35 |
| Average True Range (ATR) | 0.39 | 0.05 |
| MACD | -0.11 | -0.01 |
| Stochastic Oscillator | 30.47 | 26.28 |
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.